Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Granuloma
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Granuloma
Tree Number(s)
C15.604.515.292
C23.550.382
Unique ID
D006099
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006099
Annotation
general or unspecified; prefer specifics; coordinate with organ/disease; malignant of nose equals
GRANULOMA, LETHAL MIDLINE
; central giant cell granuloma equals
GRANULOMA, GIANT CELL
; granulomatous disease or granulomatous disease of childhood equals
GRANULOMATOUS DISEASE, CHRONIC
; cholesterol granuloma equals
GRANULOMA, FOREIGN BODY
and
CHOLESTEROL
; talc granuloma equals
GRANULOMA, FOREIGN BODY
/etiol
(not/chem ind) and
TALC
/adv eff
; xanthogranuloma equals
XANTHOMATOSIS
and
GRANULOMA
but
XANTHOGRANULOMA, JUVENILE
is available
Scope Note
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
Entry Term(s)
Granulomas
See Also
Tuberculoma
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
1999/11/03
Allowable Qualifiers
blood (BL)
cerebrospinal fluid (CF)
chemically induced (CI)
classification (CL)
complications (CO)
congenital (CN)
diagnosis (DI)
diagnostic imaging (DG)
diet therapy (DH)
drug therapy (DT)
economics (EC)
embryology (EM)
enzymology (EN)
epidemiology (EP)
ethnology (EH)
etiology (ET)
genetics (GE)
history (HI)
immunology (IM)
metabolism (ME)
microbiology (MI)
mortality (MO)
nursing (NU)
parasitology (PS)
pathology (PA)
physiopathology (PP)
prevention & control (PC)
psychology (PX)
radiotherapy (RT)
rehabilitation (RH)
surgery (SU)
therapy (TH)
urine (UR)
veterinary (VE)
virology (VI)
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Agammaglobulinemia [C15.604.515.032]
Autoimmune Lymphoproliferative Syndrome [C15.604.515.138]
Castleman Disease [C15.604.515.245]
Granuloma [C15.604.515.292]
Angiolymphoid Hyperplasia with Eosinophilia [C15.604.515.292.007]
Churg-Strauss Syndrome [C15.604.515.292.015]
Necrobiotic Xanthogranuloma [C15.604.515.292.507]
Heavy Chain Disease [C15.604.515.435]
Immunoblastic Lymphadenopathy [C15.604.515.509]
Infectious Mononucleosis [C15.604.515.516]
Leukemia, Hairy Cell [C15.604.515.553]
Leukemia, Lymphoid [C15.604.515.560]
Lymphangiomyoma [C15.604.515.562]
Lymphoma [C15.604.515.569]
Marek Disease [C15.604.515.700]
Sarcoidosis [C15.604.515.827]
Sezary Syndrome [C15.604.515.841]
Tumor Lysis Syndrome [C15.604.515.880]
Waldenstrom Macroglobulinemia [C15.604.515.925]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Acantholysis [C23.550.035]
Arrhythmias, Cardiac [C23.550.073]
Ascites [C23.550.081]
Atrial Remodeling [C23.550.113]
Azotemia [C23.550.145]
Cardiotoxicity [C23.550.161]
Channelopathies [C23.550.177]
Chromosome Aberrations [C23.550.210]
Death [C23.550.260]
Dehydration [C23.550.274]
Delayed Graft Function [C23.550.277]
Disease [C23.550.288]
Disease Attributes [C23.550.291]
Dysbiosis [C23.550.308]
Emphysema [C23.550.325]
Extravasation of Diagnostic and Therapeutic Materials [C23.550.340]
Femoracetabular Impingement [C23.550.347]
Fibrosis [C23.550.355]
Frailty [C23.550.359]
Genomic Instability [C23.550.362]
Gliosis [C23.550.369]
Granuloma [C23.550.382]
Eosinophilic Granuloma [C23.550.382.250]
Granuloma Annulare [C23.550.382.375]
Granuloma, Foreign-Body [C23.550.382.437]
Granuloma, Giant Cell [C23.550.382.468]
Granuloma, Plasma Cell [C23.550.382.875]
Granuloma, Pyogenic [C23.550.382.937]
Granuloma, Respiratory Tract [C23.550.382.968]
Necrobiotic Xanthogranuloma [C23.550.382.984]
Granulomatosis, Orofacial [C23.550.384]
Growth Disorders [C23.550.393]
Hemolysis [C23.550.403]
Hemorrhage [C23.550.414]
Hyperammonemia [C23.550.421]
Hyperamylasemia [C23.550.425]
Hyperbilirubinemia [C23.550.429]
Hyperplasia [C23.550.444]
Hyperuricemia [C23.550.449]
Hypovolemia [C23.550.455]
Inflammation [C23.550.470]
Intraoperative Complications [C23.550.505]
Ischemia [C23.550.513]
Leukoaraiosis [C23.550.522]
Leukocytosis [C23.550.526]
Lithiasis [C23.550.537]
Long Term Adverse Effects [C23.550.543]
Malacoplakia [C23.550.548]
Menstruation Disturbances [C23.550.568]
Metaplasia [C23.550.589]
Muscle Weakness [C23.550.695]
Myotoxicity [C23.550.706]
Necrosis [C23.550.717]
Neointima [C23.550.722]
Neoplastic Processes [C23.550.727]
Nerve Degeneration [C23.550.737]
Ochronosis [C23.550.744]
Ossification, Heterotopic [C23.550.751]
Ototoxicity [C23.550.753]
Pigmentation Disorders [C23.550.755]
Polydipsia [C23.550.759]
Postoperative Complications [C23.550.767]
Protein Aggregation, Pathological [C23.550.770]
Respiratory Aspiration [C23.550.773]
Retropneumoperitoneum [C23.550.794]
Sclerosis [C23.550.823]
Shock [C23.550.835]
Teratogenesis [C23.550.863]
Toxic Optic Neuropathy [C23.550.877]
Ulcer [C23.550.891]
Vascular Remodeling [C23.550.918]
Yang Deficiency [C23.550.945]
Yin Deficiency [C23.550.972]
Expand All
Collapse All
Granuloma
Preferred
Concept UI
M0009605
Scope Note
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
Terms
Granuloma
Preferred Term
Term UI
T018515
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1966)
Granulomas
Term UI
T018514
Date
11/09/1991
LexicalTag
NON
ThesaurusID
POPLINE (1978)
page delivered in 1.135s